VMD logo

Viemed Healthcare, Inc. Stock Price

NasdaqCM:VMD Community·US$471.9m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 28 Fair Values set on narratives written by author

VMD Share Price Performance

US$12.31
5.59 (83.18%)
US$11.00
Fair Value
US$12.31
5.59 (83.18%)
11.9% overvalued intrinsic discount
US$11.00
Fair Value
Price US$12.31
AnalystConsensusTarget US$11.00
AnalystHighTarget US$15.00
AnalystLowTarget US$11.00

VMD Community Narratives

·
Fair Value US$11 11.9% overvalued intrinsic discount

Ventilation, Sleep Therapy, And Maternal Health Will Expand Reach

0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
·
Fair Value US$15 17.9% undervalued intrinsic discount

US Aging And Telehealth Will Expand Home Care

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value US$11 11.9% overvalued intrinsic discount

Medicare Pressures And Competition Will Test Margins Yet Improve Resilience

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
US$15
17.9% undervalued intrinsic discount
Revenue
14.63% p.a.
Profit Margin
9.27%
Future PE
15.66x
Price in 2029
US$17.91

Trending Discussion

Updated Narratives

VMD logo

VMD: Buybacks And Stable Assumptions Will Support Balanced Share Price Outlook

Fair Value: US$11 11.9% overvalued intrinsic discount
10 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
VMD logo

VMD: Share Repurchases And Acquisition Plans Will Support Future Upside

Fair Value: US$15 17.9% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
VMD logo

Medicare Pressures And Competition Will Test Margins Yet Improve Resilience

Fair Value: US$11 11.9% overvalued intrinsic discount
3 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with proven track record.

1 Risk
3 Rewards

Viemed Healthcare, Inc. Key Details

US$286.6m

Revenue

US$121.6m

Cost of Revenue

US$165.0m

Gross Profit

US$150.1m

Other Expenses

US$14.9m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.39
57.58%
5.20%
6.3%
View Full Analysis

About VMD

Founded
2006
Employees
1387
CEO
Casey Hoyt
WebsiteView website
www.viemed.com

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Recent VMD News & Updates

Narrative Update Jun 17

VMD: Buybacks And Stable Assumptions Will Support Balanced Share Price Outlook

Analysts have maintained their price target for Viemed Healthcare at $11.00, indicating that their views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions remain unchanged. What’s in the News for Viemed Healthcare Viemed Healthcare completed a share repurchase tranche between March 4, 2026 and March 31, 2026, buying back 150,000 shares, representing 0.39% of the company, for $1.39 million, according to a buyback update.

Recent updates

No updates